Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Life Sciences RNAdvance Viral XP

Beckman Coulter Life Sciences announced the launch of its new RNA extraction kit, RNAdvance Viral XP. The kit is validated for use in infectious disease and real-time PCR virus research and is intended for use in high-throughput settings to extract viral RNA from swab samples, the firm said. After it has been extracted, the RNA is used in qRT-PCR kits to determine whether the virus is present. Danaher subsidiary Beckman Coulter worked with next-generation sequencing company iRepertoire to develop the kit's method, which iRepertoire then independently validated.